Dolutegravir use is related to lower HTLV-1 proviral load in people co-infected by HIV-1
Dolutegravir use is consistently associated with lower HTLV-1 proviral load in HIV-HTLV-1 coinfected patients. This indicates that Dolutegravir may be an effective treatment for HTLV-1 infection.
Authors
- Eduardo Martins Netto (ORCID: https://orcid.org/0000-0003-1691-6761)
- Carlos Roberto Brites (ORCID: https://orcid.org/0000-0002-4673-6991)
- María B. Arriaga (ORCID: https://orcid.org/0000-0001-6883-8422)
- Rafaela Mayoral
- Tatiana Fernandez
Institutions
- Universidade Federal da Bahia (BR)
- Complexo Hospitalar Universitário Professor Edgard Santos (BR)
Publication Details
- Journal
- Communications Medicine
- Published
- 2025-12-18
- DOI
- https://doi.org/10.1038/s43856-025-01312-9
- Primary Topic
- T-cell and Retrovirus Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00